130 related articles for article (PubMed ID: 38220428)
1. Proteomics and genomics insights on malignant osteosarcoma.
Kathiresan N; Selvaraj C; Pandian S; Subbaraj GK; Alothaim AS; Safi SZ; Kulathaivel L
Adv Protein Chem Struct Biol; 2024; 138():275-300. PubMed ID: 38220428
[TBL] [Abstract][Full Text] [Related]
2. Proteomics of osteosarcoma.
Bernardini G; Laschi M; Geminiani M; Santucci A
Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
[TBL] [Abstract][Full Text] [Related]
3. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
4. Rho A Regulates Epidermal Growth Factor-Induced Human Osteosarcoma MG63 Cell Migration.
Wang J; Zhang L; Qu R; Zhang L; Huang W
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751634
[TBL] [Abstract][Full Text] [Related]
5. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
6. Developmental pathways hijacked by osteosarcoma.
Mortus JR; Zhang Y; Hughes DP
Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
[TBL] [Abstract][Full Text] [Related]
7. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
8. Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.
Barøy T; Kresse SH; Skårn M; Stabell M; Castro R; Lauvrak S; Llombart-Bosch A; Myklebost O; Meza-Zepeda LA
Mol Cancer; 2014 Apr; 13():93. PubMed ID: 24885297
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
10. Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes.
Lauvrak SU; Munthe E; Kresse SH; Stratford EW; Namløs HM; Meza-Zepeda LA; Myklebost O
Br J Cancer; 2013 Oct; 109(8):2228-36. PubMed ID: 24064976
[TBL] [Abstract][Full Text] [Related]
11. New molecular insights into osteosarcoma targeted therapy.
Yang J; Zhang W
Curr Opin Oncol; 2013 Jul; 25(4):398-406. PubMed ID: 23666471
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor associates with survival and regulates tumour progression in osteosarcoma.
Tieken C; Verboom MC; Ruf W; Gelderblom H; Bovée JV; Reitsma PH; Cleton-Jansen AM; Versteeg HH
Thromb Haemost; 2016 May; 115(5):1025-33. PubMed ID: 26763081
[TBL] [Abstract][Full Text] [Related]
13. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
[TBL] [Abstract][Full Text] [Related]
14. Potential Molecular Mechanisms of AURKB in the Oncogenesis and Progression of Osteosarcoma Cells: A Label-Free Quantitative Proteomics Analysis.
Pi WS; Cao ZY; Liu JM; Peng AF; Chen WZ; Chen JW; Huang SH; Liu ZL
Technol Cancer Res Treat; 2018; 18():1533033819853262. PubMed ID: 31122179
[TBL] [Abstract][Full Text] [Related]
15. Biological analysis of cancer specific microRNAs on function modeling in osteosarcoma.
Wang H; Tang M; Ou L; Hou M; Feng T; Huang YE; Jin Y; Zhang H; Zuo G
Sci Rep; 2017 Jul; 7(1):5382. PubMed ID: 28710380
[TBL] [Abstract][Full Text] [Related]
16. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma.
Meng Q; Zhao J; Liu H; Zhou G; Zhang W; Xu X; Zheng M
Tumour Biol; 2014 Dec; 35(12):12265-74. PubMed ID: 25168370
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
[TBL] [Abstract][Full Text] [Related]
18. Upregulation and biological function of transmembrane protein 119 in osteosarcoma.
Jiang ZH; Peng J; Yang HL; Fu XL; Wang JZ; Liu L; Jiang JN; Tan YF; Ge ZJ
Exp Mol Med; 2017 May; 49(5):e329. PubMed ID: 28496199
[TBL] [Abstract][Full Text] [Related]
19. ARHGEF3 Associated with Invasion, Metastasis, and Proliferation in Human Osteosarcoma.
Gong J; Tang W; Lv B; Zhang S; Fan T; Gao G; Chen D; Liu Y
Biomed Res Int; 2021; 2021():3381957. PubMed ID: 34350290
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]